PHILADELPHIA (December 14, 2020) — National efforts to develop a coronavirus disease 2019 (COVID-19) vaccine at «warp speed» will likely yield a safe and effective vaccine by early 2021. However, this important milestone is only the first step in an equally important challenge: getting a majority of the U.S. public vaccinated.
Authors of a viewpoint article in the Journal of the American Medical Association share five strategies and implementation considerations, informed by insights from behavioral science, for a national COVID-19 vaccine promotion program. Alison M. Buttenheim, PhD, MBA, the Patricia Bleznak Silverstein and the Howard A. Silverstein Term Endowed Professorship in Global Women’s Health at the University of Pennsylvania School of Nursing (Penn Nursing), is senior author of the article.
«The U.S. needs a national strategy for the promotion of COVID-19 vaccines that unites the urgency and commitment of Operation Warp Speed with innovative behavioral science and social marketing approaches to increase COVID-19 vaccine confidence and acceptance in diverse populations,» she says.
The recommended strategies are:
- Make the vaccine free and easily accessible.
- Make access to valued settings conditional on getting vaccinated.
- Use public endorsements from trusted leaders to increase uptake.
- Provide priority access to people who sign up to get vaccinated before vaccines are widely available.
- Transform individual vaccination decisions into a public act.
The researchers also recommend the formation of a national entity similar to Operation Warp Speed to steer federal COVID-19 vaccine promotion efforts. «This entity should include scientists from multiple disciplines (epidemiology, vaccine science, behavioral science, social marketing, communications) as well as vaccine program delivery experts,» says Buttenheim. «The team should represent a spectrum of political views to depoliticize pandemic response.»
The article «Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program» is available online. Co-authors of the article from Penn’s Center for Health Incentives and Behavioral Economics, where Buttenheim is Scientific Director, include Kevin G. Volpp, MD, PhD, of the Cresencz Philadelphia VA Medical Center; and George Loewenstein, PhD, of Carnegie Mellon University.
About the University of Pennsylvania School of Nursing
The University of Pennsylvania School of Nursing is one of the world’s leading schools of nursing. For the fifth year in a row, it is ranked the #1 nursing school in the world by QS University and is consistently ranked highly in the U.S. News & World Report annual list of best graduate schools. Penn Nursing is currently ranked # 1 in funding from the National Institutes of Health, among other schools of nursing, for the third consecutive year. Penn Nursing prepares nurse scientists and nurse leaders to meet the health needs of a global society through innovation in research, education, and practice. Follow Penn Nursing on: Facebook, Twitter, LinkedIn, & Instagram.
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.